Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Bactiguard Holding AB (publ)
  6. News
  7. Summary
    BACTI B   SE0005878741

BACTIGUARD HOLDING AB (PUBL)

(BACTI B)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 12/03 11:29:58 am
151.8 SEK   -2.69%
11/18BACTIGUARD : Stop antimicrobial resistance through awareness
PU
11/17BACTIGUARD : ranks higher on Allbright's list of equality
PU
11/16CEO Anders Göransson invests in Bactiguard
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Bactiguard : More than 50% risk reduction of ventilator associated pneumonia with Bactiguard's Technology

10/08/2021 | 11:42am EST

A new study from Liège, Belgium, shows that the usage of Bactiguard's infection preventive endotracheal tube reduces ventilator associated pneumonia (VAP) with 53% in intensive care patients. The study VITAL was presented in the beginning of October at the European Society of Intensive Care Medicine Congress (ESICM) where it was selected as one of the top 6 best abstracts.

"Ventilator associated pneumonia (VAP) is a feared complication with high mortality. The study data indicates that by using a Bactiguard endotracheal tube, the risk of this deadly complication is significantly reduced", says Stefan Grass, Chief Medical Officer at Bactiguard.

The VITAL study is a randomized controlled study including 323 patients, who have either been intubated with a Bactiguard endotracheal tube with subglottic secretion drainage (BIP ETT Evac), or a conventional tube also with subglottic secretion drainage.

The study was presented at the European Society of Intensive Care Medicine on October 4th 2021.

Bactiguard's BIP ETT Evac

Disclaimer

Bactiguard Holding AB published this content on 08 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 October 2021 15:41:02 UTC.


ę Publicnow 2021
All news about BACTIGUARD HOLDING AB (PUBL)
11/18BACTIGUARD : Stop antimicrobial resistance through awareness
PU
11/17BACTIGUARD : ranks higher on Allbright's list of equality
PU
11/16CEO Anders Göransson invests in Bactiguard
AQ
10/29Nomination Committee appointed for the Annual General Meeting 2022
AQ
10/29Bactiguard Holding AB Appoints Nomination Committee
CI
10/28Interim report for Q3 2021
AQ
10/28Bactiguard Holding AB Reports Earnings Results for the Third Quarter and Nine Months En..
CI
10/25BACTIGUARD : Invitation to presentation of Bactiguard's interim report on October 28, 2021
PU
10/25BACTIGUARD : Invitation to presentation of Bactiguard's interim report on October 28, 2021
AQ
10/08BACTIGUARD : More than 50% risk reduction of ventilator associated pneumonia with Bactigua..
PU
More news
Financials
Sales 2020 177 M 19,3 M 19,3 M
Net income 2020 -38,4 M -4,19 M -4,19 M
Net Debt 2020 254 M 27,8 M 27,8 M
P/E ratio 2020 -125x
Yield 2020 -
Capitalization 5 320 M 581 M 581 M
EV / Sales 2019 15,5x
EV / Sales 2020 28,6x
Nbr of Employees -
Free-Float 36,4%
Chart BACTIGUARD HOLDING AB (PUBL)
Duration : Period :
Bactiguard Holding AB (publ) Technical Analysis Chart | BACTI B | SE0005878741 | MarketScreener
Technical analysis trends BACTIGUARD HOLDING AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Anders G÷ransson Chief Executive Officer
Gabriella Bj÷rknert Caracciolo Chief Financial Officer & Deputy CEO
Nils Thomas von Koch Chairman
Stefan Grass Chief Medical Officer & Deputy CEO
Sathish Subramaniam Chief Operations Officer